References
- Giannini A. J., Price W. A. The dissociatives. Med. Psychiatry, in press
- Giannini A. J., Price W. A. Phencyclidine and the dissociatives. Clinical Foundations of Biological Psychiatry, A. J. Giannini. Medical Examination/Excerpta Medica, New Hyde Park 1985; 339–346
- Schlemmer R. F., Jackson J. A., Preston K. L. Phencyclidine induced stereotyped behavior in monkeys. Eur. J. Pharmacol. 1978; 52: 379–384
- Smith R. C., Meltzer H. Y., Arora R. C., Davis J. M. Effects of phencyclidine on H-serotonin uptake in synaptosomal preparations from rat brain. Biochem. Pharmacol. 1977; 26: 1435–1439
- Castellani S., Giannini A. J., Adams P. M. Physostigmine and haloperidol treatment of acute phencyclidine intoxication. Am. J. Psychiatry 1982; 139: 508–510
- Castellani S., Giannini A. J., Boeringo J., Adams P. Phencyclidine intoxication: assessment of possible antidotes. Clin. Toxicol. 1982; 19: 313–319
- Giannini A. J., Eighan M. S., Loiselle R. H. Comparison of haldol and chlorpromazine in the treatment of PCP psychosis. J. Clin. Pharmacol. 1984; 24: 202–204
- Giannini A. J., Kalavsky S., Giannini M. C. Receptor specificity in PCP psychosis. Neurosci. Abst. 1983; 9: 33
- Snyder S. H. Dopamine receptors, neuroleptics and schizophrenia. Am. J. Psychiatry 1981; 138: 460–464
- Creese I., Leff S. E. Dopamine receptors: a classification. J. Clin. Psychopharmacol. 1982; 2: 329–335
- Giannini A. J., Giannini M. C., Price W. A. Antidotal strategies in phencyclidine intoxication. Int. J. Psychiatry Med. 1984; 14: 315–321
- Creese I., Morrow A. L., Leff S. E., Sibley D. R., Hamblin M. W. Dopamine receptors in the central nervous system. Int. Rev. Neurobiol. 1982; 23: 255–301
- Couinard G., Annable L. Pimozide in treatment of newly admitted schizophrenic patients. Psychopharmacol. 1982; 76: 13–19
- Nose T., Takamoto H. The effect of penfluridol and some psychotic drugs on monamine metabolism in central nervous system. Eur. J. Pharmacol. 1975; 31: 351–359
- Seeman P., Lee T. Antipsychotic drugs: direct correlations between clinical potency and presynaptic action on dopamine neurons. Science 1975; 188: 1217–1219
- Hauger R. L., Paul S. M. Neuropharmacology of antipsychotic agents. Clinical Foundations of Biological Psychiatry, A. J. Giannini. Medical Examination/Excerpta Medica, New Hyde Park 1985; 274–296
- Castellani S., Adams P., Giannini A. J. Physostigmine treatment of acute phencyclidine intoxication. J. Clin. Psychiatry 1982; 43: 10–11
- Farah J. M., Malcolm D. S., Mueller G. V. Dopaminergic onhibition of pituitary B-endorphin-like immunoreactivity serotonin in the rate. Endocrinol. 1982; 110: 657–659
- Bozarth M. A., Wise R. A. Heroin reward is dependent on a dopaminergic substrate. Life Sci. 1981; 29: 1881–1886
- Castellani S., Giannini A. J., Adams P. Behavioral effects of naloxone, metenkephlin and morphine on phencyclidine-induced behavior in the rat. Psychopharmacol. 1982; 78: 76–78
- Giannini A. J., Price W. A., Loiselle R. H. Meperidine versus chlorpromazine in the treatment of PCP psychosis. J. Clin. Psychiatry. 1985; 46: 52–54
- Su T. P., Cone J., Shannon H. Relative potencies of phencyclidine and analogs in the opiate receptor binding assay: correlations with relative potencies in vivo in mouse and rat. Research in Community Substance Abuse 1980; 1: 85–90